Slingshot members are tracking this event:
GlycoMimetics Announces Pricing of Public Offering of Common Stock
Do you think this event is important to the companies below? How will it affect their stock price?
|Impact on Stocks
|GLYC||Community voting in process|
GlycoMimetics intends to use the net proceeds of the offering to conduct planned clinical trials of GMI-1271, to fund the research and development of its preclinical pipeline, including drug discovery, and for working capital and other general corporate purposes.
Slingshot Insights Explained
Jun 17, 2016
Don’t see a project related to the catalyst you care about?
Related Keywords Public Offering, Gmi-1271